Author:
Hilgenfeld R. U.,Kreuser E. D.
Publisher
Springer Berlin Heidelberg
Reference193 articles.
1. Aaronson NK, Ahmedzai S, Bullinger M (1993) The European Organisation for Research and Treatment of Cancer QLQ-C-30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85: 333–338
2. Abad A, Rosell R Pastor MC, Barnadas A, Carles J, Ribelles N, Oller B, Armengol M, Salva R, Ribas M (1991) Sequential combination of methotrexate (MTX), 5-fluorouracil (FU), and high-dose folinic acid (FA) in advanced colorectal cancer: double biochemical modulation? Am J Clin Oncol 14: 393–396
3. Abad A, Garcia P, Grávalos C, Tusquets I, Rosell R, Perez-Manga G, Cortés-Funes H, Fabregat X, Barnadas A (1992) Phase III trial with methotrexate, 5-FU and high-dose leucovorin (MFL) vs 5-FU, leucovorin (FL) vs 5-FU (F) in advanced and metastatic colorectal cancer. Proc Am Soc Clin Oncol 11: 161 (abstr)
4. Abbruzzese JL, Grunewald R, Weeks EA, Gravel D, Adams T, Nowak B, Mineishi S, Tarassoff P, Satterlee W, Raber MN, Plunkett W (1991) A phase I clinical, plasma, and cellular pharmacology study of gemcitabine. J Clin Oncol 9: 491–498
5. Advanced Colorectal Cancer Meta-Analysis Project (1992) Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rates. J Clin Oncol 10: 896–903
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献